Fluorouracil (5FU) MarketSize and Trends

Global Fluorouracil (5FU) Market – Drivers

The rising prevalence of non-communicable diseases such as cancer is major burden. Fluorouracil is the most potent and effective first line drug treatment for cancer. Thus pharmaceutical companies are investing in research and development activities which is expected to support growth of this market. For instance, in 2016, Shire plc announced that the European Commission has granted approval to ONIVYDE for treatment of metastatic adenocarcinoma of pancreas in combination with 5-fluorouracil and leucovorin in treatment of adults. Moreover, in 2019, Accord Healthcare announced that they have launched a fluorouracil injection in Australia. These factors are expected to drive the global fluorouracil market growth.

Global Fluorouracil (5FU) Market – Impact of COVID-19

Since the outbreak of COVID-19 in 2019, the disease has spread throughout the world and hampered growth of several markets across the globe. The growth of the global fluorouracil market is expected to get hampered, According to National Cancer Institute United States, some cancer treatment such as chemotherapy can lower immune system in cancer patient and may increase risk of COVID-19 in cancer patients. Whereas fluorouracil is first line chemotherapy drug used for treatment of cancer patients. Thus may increase risk for cancer patient of getting infected by COVID-19. Nationwide lockdown in several countries across the globe has led to a reduction in production capacity of pharmaceutical companies due to less manpower. Moreover, the pandemic has directly affected production and demand of products across the global market. Moreover, it has also disrupted the supply chain in the market as a result of lockdowns across the globe.